PND28 - A BUDGET IMPACT ANALYSIS OF CLADRIBINE TABLETS VERSUS ALTERNATIVE HIGH EFFICACY TREATMENTS FOR RELAPSING MULTIPLE SCLEROSIS (RMS) IN THE UNITED KINGDOM.
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1995
https://www.valueinhealthjournal.com/article/S1098-3015(18)35297-5/fulltext
Title :
PND28 - A BUDGET IMPACT ANALYSIS OF CLADRIBINE TABLETS VERSUS ALTERNATIVE HIGH EFFICACY TREATMENTS FOR RELAPSING MULTIPLE SCLEROSIS (RMS) IN THE UNITED KINGDOM.
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35297-5&doi=10.1016/j.jval.2018.09.1995
First page :
Section Title :
Open access? :
No
Section Order :
1349